Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
AHA 2025
Comparing cardiovascular outcomes in new users of oral semaglutide versus other noninsulin glucose-lowering therapies
AHA 2025
AHA 2025
7 - 10 November 2025
Comparing cardiovascular outcomes in new users of oral semaglutide versus other noninsulin glucose-lowering therapies
Authors
:
Xi Tan
1
; Yuanjie Liang
1
; Caichen Zhong
1
; Lin Xie
1
; Mico Guevarra
1
; Caroline Swift
1
; Adam de Havenon
2
Affiliations
View Details
Hide Details
Download poster (.pdf)
Share
Copy link
{{pageUrl}}
Keywords
Diabetes
Congress poster
GLP-1 RA
Semaglutide (oral)
RWE HEOR